[go: up one dir, main page]

DK1282639T3 - Polyamidnucleinsyrederivater, midler og fremgangsmåder til fremstilling heraf - Google Patents

Polyamidnucleinsyrederivater, midler og fremgangsmåder til fremstilling heraf

Info

Publication number
DK1282639T3
DK1282639T3 DK01919443T DK01919443T DK1282639T3 DK 1282639 T3 DK1282639 T3 DK 1282639T3 DK 01919443 T DK01919443 T DK 01919443T DK 01919443 T DK01919443 T DK 01919443T DK 1282639 T3 DK1282639 T3 DK 1282639T3
Authority
DK
Denmark
Prior art keywords
agents
preparation
methods
nucleic acid
acid derivatives
Prior art date
Application number
DK01919443T
Other languages
English (en)
Inventor
Eugen Uhlmann
David William Will
Gerhard Breipohl
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1282639T3 publication Critical patent/DK1282639T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polyamides (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK01919443T 2000-04-18 2001-04-07 Polyamidnucleinsyrederivater, midler og fremgangsmåder til fremstilling heraf DK1282639T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10019136A DE10019136A1 (de) 2000-04-18 2000-04-18 Polyamidnukleinsäure-Derivate, Mittel und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
DK1282639T3 true DK1282639T3 (da) 2005-12-12

Family

ID=7639144

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01919443T DK1282639T3 (da) 2000-04-18 2001-04-07 Polyamidnucleinsyrederivater, midler og fremgangsmåder til fremstilling heraf

Country Status (19)

Country Link
US (2) US6777544B2 (da)
EP (1) EP1282639B1 (da)
JP (1) JP5149475B2 (da)
KR (1) KR100815067B1 (da)
AR (1) AR030210A1 (da)
AT (1) ATE302212T1 (da)
AU (2) AU4653601A (da)
BR (1) BR0110111A (da)
CA (1) CA2406168C (da)
DE (2) DE10019136A1 (da)
DK (1) DK1282639T3 (da)
ES (1) ES2246318T3 (da)
IL (2) IL152287A0 (da)
MX (1) MXPA02009738A (da)
NO (1) NO328910B1 (da)
NZ (1) NZ522005A (da)
TW (1) TWI318213B (da)
WO (1) WO2001079249A2 (da)
ZA (1) ZA200208346B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10019135A1 (de) * 2000-04-18 2001-10-31 Aventis Pharma Gmbh Polyamidnukleinsäure-Derivate, Mittel und Verfahren zu ihrer Herstellung
US7270954B1 (en) * 2000-06-30 2007-09-18 Iris Biotechnologies, Inc. Hybridization of target DNA with immobilized nucleic acid analogs
DE10159904A1 (de) * 2001-12-06 2003-07-03 Adnagen Ag Oligonukleotidanordnung, Verfahren zum Nukleotidnachweis sowie Vorrichtung hierfür
US7371852B2 (en) * 2003-01-22 2008-05-13 Serenex, Inc. Alkyl-linked nucleotide compositions
DE102006050091A1 (de) * 2006-10-24 2008-09-11 Ugichem Gesellschaft für Organische Chemie mbH Verfahren zur selektiven Lokalisierung von Wirkstoffen an und in Mitochondrien und entsprechende Wirkstoffe
WO2008150832A1 (en) * 2007-05-31 2008-12-11 Sanofi-Aventis Assay methods for identifying agents that modify the activity of nape-pld or abh4
KR20090098710A (ko) 2008-03-14 2009-09-17 주식회사 씨티아이바이오 세포투과성과 핵산 결합력이 좋은 펩타이드 핵산 유도체
TWI531370B (zh) * 2010-05-14 2016-05-01 可娜公司 藉由抑制ｐａｒ４天然反股轉錄本治療ｐａｒ４相關疾病
JP6937294B2 (ja) 2015-09-16 2021-09-22 ぺタオミクス， インコーポレイテッド ゲノムターゲットエンリッチメント及び選択的ｄｎａシーケンシングのための方法及び組成物
US12492423B2 (en) 2015-09-16 2025-12-09 PetaOmics, Inc. Methods and compositions for genomic target enrichment and selective DNA sequencing

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK51092D0 (da) * 1991-05-24 1992-04-15 Ole Buchardt Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf
DE4408531A1 (de) * 1994-03-14 1995-09-28 Hoechst Ag PNA-Synthese unter Verwendung einer gegen schwache Säuren labilen Amino-Schutzgruppe
DE69527857T2 (de) * 1994-10-06 2003-05-28 Buchardt, Dorte Peptid-nukleinsäure-konjugate
DE19508923A1 (de) * 1995-03-13 1996-09-19 Hoechst Ag Phosphonomonoesternukleinsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung
DE59607750D1 (de) 1995-03-13 2001-10-31 Aventis Pharma Gmbh Phosphonomonoesternnukleinsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19640974A1 (de) * 1996-10-04 1998-04-16 Bayer Ag Bausteine für DNA/PNA-Cooligomere
DE19757516A1 (de) * 1997-12-23 1999-06-24 Roche Diagnostics Gmbh Modifizierte Nukleinsäureanaloga
US6043352A (en) * 1998-08-07 2000-03-28 Isis Pharmaceuticals, Inc. 2'-O-Dimethylaminoethyloxyethyl-modified oligonucleotides

Also Published As

Publication number Publication date
EP1282639B1 (de) 2005-08-17
US20030022172A1 (en) 2003-01-30
DE50107121D1 (de) 2005-09-22
AR030210A1 (es) 2003-08-13
NO328910B1 (no) 2010-06-14
TWI318213B (en) 2009-12-11
CA2406168A1 (en) 2001-10-25
KR20030036167A (ko) 2003-05-09
US6777544B2 (en) 2004-08-17
IL152287A (en) 2009-09-22
AU2001246536B2 (en) 2007-02-15
NO20024960L (no) 2002-11-12
WO2001079249A2 (de) 2001-10-25
WO2001079249A3 (de) 2002-03-28
MXPA02009738A (es) 2003-03-12
US7241882B2 (en) 2007-07-10
NZ522005A (en) 2004-12-24
KR100815067B1 (ko) 2008-03-20
BR0110111A (pt) 2003-02-11
ZA200208346B (en) 2003-10-07
NO20024960D0 (no) 2002-10-15
ES2246318T3 (es) 2006-02-16
JP5149475B2 (ja) 2013-02-20
US20040265885A1 (en) 2004-12-30
EP1282639A2 (de) 2003-02-12
ATE302212T1 (de) 2005-09-15
AU4653601A (en) 2001-10-30
JP2004502649A (ja) 2004-01-29
DE10019136A1 (de) 2001-10-31
IL152287A0 (en) 2003-05-29
CA2406168C (en) 2012-01-24

Similar Documents

Publication Publication Date Title
DK1180518T3 (da) 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
DK1268431T3 (da) 3-Cyanoquinoliner, 3-cyano-1,6-naphthyridiner og 3-cyano-1,7-naphthyridiner som proteinkinaseinhibitorer
NO20032332D0 (no) Benzodiazepinderivatforbindelser, fremgangsmåte til fremstilling og anvendelse derav
NO20024959L (no) Polyamidnukleinsyrederivater, midler og fremgangsmÕter for deres fremstilling
DK1511734T3 (da) Forbindelser, præparater og fremgangsmåder
DK1265482T3 (da) Vandige formulationer og fremgangsmåde til fremstilling af samme
DK1334106T3 (da) Imidazolderivater, fremstillingsmetoder deraf og anvendelse deraf
DK1282639T3 (da) Polyamidnucleinsyrederivater, midler og fremgangsmåder til fremstilling heraf
IS7798A (is) Efnasambönd, lyfjablöndur og aðferðir
NO20053809D0 (no) Diarylmetylindenpiperidinderivater,fremgangsmate for fremstilling derav, og anvendelse derav
NO20022969L (no) Sammensetninger og metoder for L-nukleosider, L-nukleotider og analoger derav
NO20033120L (no) 2-arylimino-2,3-dihydrotiazolderivater, fremgangsmåter for fremstilling derav og terapeutisk anvendelse derav
NO20024105L (no) Memnopeptider, fremgangsmåte for deres fremstilling og anvendelse av disse
DK1086077T3 (da) Hidtil ukendte antiestrogener, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse
NO20030375D0 (no) N-substituerte 1-amino-1,1-dialkylkarboksylsyrederivater
NO20053805D0 (no) Diarylmetylindenpiperidinderivater, framgangsmate for fremstilling derav, og anvendelse derav
NO20033965D0 (no) Caloporosidderivater, fremgangsmåte for deres fremstilling og deres anvendelse
DK1146044T3 (da) CNS-aktive cyclobutaindolcarboxamidderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DK1259523T3 (da) Pluraflaviner og derivater deraf, fremgangsmåde til fremstilling og anvendelse deraf
DK1404663T3 (da) Eurotinoner og derivater deraf, fremgangsmåde til deres fremstilling og anvendelse heraf
NO20011921D0 (no) Sulfidoamidokarboksylsyrer, metoder for fremstilling derav og anvendelser derav
DK1200446T3 (da) Oxathiepino[6,5-b]dihydropyridiner og beslægtede forbindelser og fremgangsmåder
DK1324980T3 (da) Citrullimyciner, og fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
AU2001254795B2 (en) Polyamide nucleic acid derivatives, agents and methods for producing them
DK1337528T3 (da) Benzothiophenderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf